Tempus named to TIME's top 10

Tempus AI said on April 28 that TIME named it to the magazine’s inaugural list of the 10 most influential health and life-science companies of 2026. (time.com) (tempus.com) TIME’s writeup pointed to Tempus’ xT CDx test, a 648-gene tissue-based sequencing assay for malignant solid tumors, and to the company’s use of artificial intelligence in clinical analysis. (time.com) (finance.yahoo.com) On April 29, Tempus said it will hold its first investor day on Friday, May 29, starting at 8:00 a.m. Central time, with a live webcast and invitation-only in-person attendance. (businesswire.com) The company said founder and chief executive Eric Lefkofsky, chief financial officer Jim Rogers, data and applications chief executive Ryan Fukushima, diagnostics chief executive Tom Schoenherr, and chief scientific officer Kate Sasser will present. (businesswire.com) Tempus sells a kind of medical matching system: it combines lab tests, patient records, and other health data so doctors and drug developers can compare one case with many others. The company describes that pool as one of the world’s largest libraries of multimodal data. (businesswire.com 1) (businesswire.com 2) That pitch has been translating into growth. Tempus reported fourth-quarter 2025 revenue of $367.2 million, up 83.0% from a year earlier, and guided to $1.59 billion in revenue for 2026. (businesswire.com) Its diagnostics business brought in $266.9 million in fourth-quarter revenue, while data and applications added $100.4 million; the company also said it ended 2025 with more than $1.1 billion in remaining contract value. (businesswire.com) TIME’s new sector list puts Tempus alongside larger drugmakers and health-technology groups in a year when obesity drugs, cancer tools, and artificial-intelligence systems dominated health-company rankings. (time.com) The investor day gives Tempus a separate stage to explain how its diagnostics arm and its data-licensing and software businesses fit together after that run of growth. (businesswire.com 1) (businesswire.com 2) For now, the sequence is straightforward: a TIME honor on April 28, then a May 29 investor event aimed at showing investors what Tempus says comes next. (tempus.com) (businesswire.com)